Table 2 Patients’ data (subgroups IIA and IIB)
|  | Non-insulin No. of patients = 981 | Insulin No. of patients = 232 | p value |
|---|---|---|---|
Age (years) | 65 ± 10 | 64 ± 10 | 0.023 |
Males | 775 (79%) | 172 (74%) | 0.113 |
Elective | 627 (65%) | 149 (65%) | 1.000 |
NYHA FC III–IV | 284 (26%) | 88 (31%) | 0.003 |
Previous operation | 28 (3%) | 9 (4%) | 0.399 |
Ejection fraction (%) | 51 ± 11 | 47 ± 12 | 0.000 |
Logistic EuroSCORE | 6 ± 9 | 8 ± 11 | 0.012 |
Hypertension | 847 (86%) | 205 (88%) | 0.453 |
COPD | 51 (5%) | 10 (4%) | 0.738 |
Dialysis | 12 (1%) | 12 (5%) | 0.001 |
Hyperlipidemia | 818 (83%) | 201 (87%) | 0.273 |
PVD | 125 (13%) | 60 (26%) | 0.000 |
CVA/TIA | 106 (11%) | 24 (10%) | 0.906 |
Pulmonary hypertension | 10 (1%) | 6 (3%) | 0.099 |
Arrhythmia | 2 (0.2%) | 4 (2%) | 0.014 |
LIMA | 949 (97%) | 222 (96%) | 0.426 |
Double mammary | 396 (40%) | 72 (31%) | 0.032 |
Number of grafts | 3 ± 1 | 3 ± 1 | 0.231 |
Bypass | 83 ± 42 | 81 ± 40 | 0.471 |
Clamp | 57 ± 31 | 53 ± 17 | 0.014 |
Mini invasive | 18 (2%) | 3 (1%) | 0.781 |